-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Complement and Innate Immunity

Program: General Sessions
Session: Presidential Symposium
Tuesday, December 12, 2023, 11:00 AM-12:30 PM

Lubka T. Roumenina, PhD

Sorbonne Université, Paris, France; Centre de Recherche des Cordeliers, INSERM, Paris, France

Disclosures: Roumenina: Roche: Research Funding; CSL Behring: Research Funding; Novartis: Research Funding; CommitBio: Consultancy, Research Funding.

See more of: Presidential Symposium
See more of: General Sessions
Previous Presentation | Next Presentation >>